COMPOSITION FOR TREATING OR PREVENTING DIABETES TYPE II, OBESITY, OR HYPERLIPIDEMIA COMPRISING GYPENOSIDE EXTRACT OF GYNOSTEMMA PENTAPHYLLUM

摘要

PURPOSE: A gypenoside extract of Gynostemma pentaphyllum containing a large amount of gepenoside UL1-UL7 and known gepenoside XL VIII is provided to suppress obesity, to treat diabetes, and to improve lipid in blood. CONSTITUTION: A pharmaceutical composition for preventing or treating type 2 diabetes, obesity, or hyperlipidemia contains a gypenoside extract of Gynostemma pentaphyllum as an active ingredient, containing one or more dammarane-based saponin compounds selected from the group consisting of gypenoside UL1, gypenoside UL2, gypenoside UL3, gypenoside UL4, gypenoside UL5, gypenoside UL6, gypenoside UL7, and gypenoside XL VIII. The extract contains 60-95wt% of the dammarane-based saponin compounds.